Results 71 to 80 of about 8,274 (166)

Healthcare Resource Utilisation and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Analysis of German Insurance Claims Data

Rheumatology and Therapy
Introduction Evidence is limited on the clinical and economic burden of eosinophilic granulomatosis with polyangiitis (EGPA) in Europe. We evaluated EGPA healthcare resource utilisation (HCRU), days off work, and costs in Germany.
Paul Dolin, Anat Shavit, Jennifer Rowell, Chris Edmonds, Josefine Persson, Danuta Kielar, Keltie McDonald, Antje Mevius, Bernhard Hellmich, Stephanie Y. Chen   +9 more
doaj   +1 more source

Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK

ERJ Open Research
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare but serious disease characterised by the combination of small-to-medium vessel vasculitis, blood and tissue eosinophilia, and asthma and/or sinonasal disease.
Jeremiah Hwee, Lorraine Harper, Qinggong Fu, Krishnarajah Nirantharakumar, George Mu, Rupert W. Jakes   +5 more
doaj   +1 more source

Impact of Severe COVID‐19 on Interstitial Lung Disease in Autoimmune Systemic Diseases

Respirology Case Reports, Volume 14, Issue 9, September 2026.
In this multicentre case series of 27 patients with autoimmune systemic diseases, severe COVID‐19 pneumonia led to marked interstitial lung disease (ILD) worsening, with new‐onset or progressive ILD in all survivors and NSIP‐to‐UIP transition in six cases.
Clodoveo Ferri, Marco de Pinto, Giuseppe Murdaca, Giacomo De Luca, Davide Mohammad Reza Beigi, Virginia Caira, Roberta Foti, Andrea Cito, Caterina Naclerio, Jessica Maria Elisa Luppino, Amelia Spinella, Martina Orlandi, Veronica Batani, Federica Lumetti, Francesco Prampolini, Giuseppe Varcasia, Rosario Foti, Valeria Riccieri, Florenzo Iannone, Alessandro Antonelli, Dilia Giuggioli, the COVID‐19 and Autoimmune Systemic Diseases Italian Study Group, Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, Laura Gragnani, Serena Lorini, Lorenzo Dagna, Silvia Laura Bosello, Rosario Foti, Valeria Riccieri, Serena Guiducci, Giovanna Cuomo, Antonio Tavoni, Rossella De Angelis, Fabio Cacciapaglia, Elisabetta Zanatta, Franco Cozzi, Giuseppe Murdaca, Ilaria Cavazzana, Nicoletta Romeo, Veronica Codullo, Roberta Pellegrini, Giuseppe Varcasia, Maria De Santis, Carlo Selmi, Giuseppina Abignano, Maurizio Caminiti, Massimo L’Andolina, Domenico Olivo, Ennio Lubrano, Amelia Spinella, Federica Lumetti, Marco de Pinto, Giacomo De Luca, Veronica Batani, Piero Ruscitti, Teresa Urraro, Marcella Visentini, Silvia Bellando‐Randone, Elisa Visalli, Davide Testa, Gabriella Sciascia, Francesco Masini, Greta Pellegrino, Francesca Saccon, Eugenia Balestri, Giusy Elia, Silvia Martina Ferrari, Antonio Tonutti, Francesca Dall’Ara, Giuseppa Pagano Mariano, Giorgio Pettiti, Giovanni Zanframundo, Raffaele Brittelli, Vincenzo Aiello, Ylenia Dal Bosco, Roberta Foti, Ilenia Di Cola, Daniela Scorpiniti, Enrico Fusaro, Tommaso Ferrari, Pietro Gigliotti, Corrado Campochiaro, Francesca Francioso, Carlo Iandoli, Virginia Caira, Anna Linda Zignego, Salvatore D’Angelo, Franco Franceschini, Marco Matucci‐Cerinic, Roberto Giacomelli, Andrea Doria, Poupak Fallahi, Florenzo Iannone, Alessandro Antonelli   +95 more
wiley   +1 more source

Immunological and epithelial barrier dysfunction in EGPA: the possible role of new biomarkers [PDF]

Exploration of Asthma & Allergy
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis with heterogeneous clinical manifestations. Identifying reliable biomarkers is crucial to predicting disease evolution and guiding therapy.
Cristiano Caruso, Ilaria Baglivo, Stefania Colantuono, Maria Antonietta Zavarella, David Longhino, Chiara Laface, Laura Bruno, Gabriele Lucca, Fabio Romano Selvi, Eleonora Di Carluccio, Gabriele Ciasca, Umberto Basile, Benedetta Niccolini, Mario Rigante, Eugenio De Corso, Antonio Gasbarrini, Giovanni Battista Capoccetta, Paola Anselmi, Aikaterini Detoraki, Elisabetta Greco, Benedetta Bondi, Vincenzo Patella, Stefano Del Giacco   +22 more
doaj   +1 more source

Eosinophilic granulomatosis with polyangitis (eGPA)

, 2021
Summary: • Eosinophilic granulomatosis with polyangitis (eGPA or Churg-Strauss) o Presentation key features: > Orbital inflammatory syndrome • Redness, pain, lid edema, diplopia, ophthalmoplegia, optic neuropathy > Vasculitis-like presentation • Stroke o
Andrew G. Lee, MD; Nicole Weber
core  

Conclusion: EGPA, EPPA and the Future of Public Administration in Europe

, 2018
This chapter outlines the strategy of the European Group for Public Administration (EGPA) and reflects on some of its key strengths, and how these may equip the European community of scholars and practitioners of public administration (PA) to contribute ...
Bouckaert, Geert, Werner Jann, Edoardo Ongaro, Sofiane Sahraoui, Sofiane, Sahraoui, Geert Bouckaert, Fabienne Maron, Maron, Fabienne, Jann, Werner (Prof. Dr.), Ongaro, Edoardo, Sahraoui, Sofiane, Jann, Werner   +11 more
core   +1 more source

Blood Leukocyte Characterisation in Eosinophilic Granulomatosis with Polyangiitis (EGPA)

Introduction: Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare, autoimmune condition, preceded by asthma and/or chronic rhinosinusitis symptoms, later developing blood and tissue eosinophilia, along with vasculitis and granuloma formation ...
Rebecca B. Dale (22309928)
core   +1 more source

Successful benralizumab therapy for severe asthma secondary to EGPA refractory to mepolizumab [PDF]

Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a multisystem inflammatory disease. It presents a type 2 inflammatory profile and IL-5 overexpression which stimulates eosinophil production and contributes to the development of severe ...
Andrea Ofelia García Vaca, Claudine Isela Nava Ramírez   +1 more
core   +1 more source

Long-term efficacy of mepolizumab on eosinophilic granulomatosis with polyangiitis: a retrospective study [PDF]

Exploration of Asthma & Allergy
Aim: Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis characterized by eosinophilic inflammation. Patients with EGPA are treated with systemic glucocorticoids and immunosuppressive drugs to induce and maintain remission. However, most
Takahiro Matsuyama, Hiromi Matsuyama, Yoichi Dotake, Masashi Oniwa, Kentaro Tsuruzono, Hiroko Uchida, Shunsuke Yasuda, Kiyotaka Kondo, Koichi Takagi, Takayuki Suetsugu, Jun Iwakawa, Kentaro Machida, Keiko Mizuno, Kentaro Tanaka, Hiromasa Inoue   +14 more
doaj   +1 more source

PO:36:244 | Early diagnosis in eosinophilic granulomatosis with polyangiitis: a multidisciplinary approach

Reumatismo
Background. Early diagnosis of Eosinophilic Granulomatosis with Polyangiitis (EGPA) remains one of the major unmet needs in clinical practice due to the non-specific nature of prodromal symptoms and the lack of specific biomarkers, particularly in ...
Società Italiana di Reumatologia
doaj